Analysis Group (United States)
In research, Analysis Group (United States) stands highest in Medicine (#4,245 of 10,443 worldwide) and Health Sciences (#5,528 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 5.0× its share of world research.
- World rank, 2022–2025
- #9,798 of 28,054 · #6,051 all time
- Rank in United States
- #1,307 of 4,192
- Research works
- 1.8k ▲ 10% vs 2013–17
- Citations
- 54k 29.3 per fractional work
- Top-10% rate
- 15.0% record average 16.5%
- Open access
- 43% world 28%
What is Analysis Group (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,245 of 10,443 | 12.9% | 230 | #3078 | |
| Health SciencesDomain | #5,528 of 11,982 | 13.5% | 240 | #3878 |
Each strip is that field’s whole ranked pool, with the notch where Analysis Group (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Analysis Group (United States) specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 5.0× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 29.5 works5.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 3.2×. Every wedge is a field page.
- Economics, Econometrics and Finance 3.2×
- Medicine 3.1×
- Immunology and Microbiology 2.9×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Pharmacology, Toxicology and Pharmaceutics 1.0×
- Health Professions 0.9×
- Nursing 0.7×
- Mathematics 0.6×
- Psychology 0.6×
- Neuroscience 0.5×
- Business, Management and Accounting 0.5×
- Chemistry 0.3×
- Social Sciences 0.3×
- Computer Science 0.3×
- Decision Sciences 0.3×
- Chemical Engineering 0.2×
- Physics and Astronomy 0.2×
- Materials Science 0.2×
- Arts and Humanities 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.2×
- Energy 0.2×
- Environmental Science 0.2×
- Dentistry 0.2×
- Earth and Planetary Sciences 0.1×
Who are the top researchers at Analysis Group (United States)?
Ranked on the composite score, Howard G. Birnbaum, Raluca Ionescu‐Ittu and Ambika Satija lead among researchers whose main affiliation is Analysis Group (United States).
- 1 Howard G. Birnbaum United States · #91,077 worldwide 186 citations · 35 works
- 2 Raluca Ionescu‐Ittu United States · #153,010 worldwide 226 citations · 20 works
- 3 Ambika Satija United States · #207,591 worldwide 217 citations · 18 works
- 4 Urvi Desai United States · #208,182 worldwide 93 citations · 22 works
- 5 Eric Q. Wu United States · #264,116 worldwide 180 citations · 59 works
- 6 Dendy Macaulay United States · #331,135 worldwide 74 citations · 17 works
- 7 Mei Lü United States · #395,876 worldwide 72 citations · 24 works
- 8 Michael Smith United States · #466,539 worldwide 64 citations · 25 works
- 9 Fan Mu United States · #509,326 worldwide 49 citations · 25 works
- 10 Noam Y. Kirson United States · #570,800 worldwide 43 citations · 25 works
Which keywords describe research at Analysis Group (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Prognostic Factors, Chemotherapy, Immunotherapy, Rituximab, Genetics and Diagnosis.
- Gene Expression Profiling
- Antiretroviral Therapy
- Genomic Profiling
- Cost of Care
- Thrombosis
- PET Imaging
- Genomic Aberrations
- Tumor Microenvironment
- Health Utility Measures
- Lymphoma
- Autoantibodies
- Heart Failure
- Chronic Kidney Disease
- Management
- Genetic Mutations
- Rituximab
- Prognostic Factors
- Quality of Life
- Chemotherapy
- Treatment
- Epidemiology
- Inflammation
- Diagnosis
- Immunotherapy
- Genetics
- Clinical Trials
- Classification
- Biomarkers
- Clinical Practice Guidelines
- Treatment Guidelines
- Therapeutic Targets
- Cost-effectiveness Analysis
- Guidelines
- Chronic Lymphocytic Leukemia
- Targeted Therapy
- Immunology
- Asthma
- Financial Toxicity
- Pulmonary Hypertension
- Eosinophilia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology42▲ 2.8×75 topics
- Treatment21▲ 4.5×26 topics
- Inflammation19▲ 2.4×41 topics
- Chemotherapy16▲ 6.0×21 topics
- Diagnosis16▲ 4.4×22 topics
- Quality of Life15▲ 2.8×24 topics
- Immunotherapy15▲ 5.6×14 topics
- Prognostic Factors15▲ 9.1×11 topics
- Genetics14▲ 5.4×14 topics
- Rituximab13▲ 23×4 topics
- Clinical Trials12▲ 4.8×12 topics
- Genetic Mutations11▲ 6.9×17 topics
- Classification11▲ 6.0×4 topics
- Management10▲ 3.3×18 topics
- Biomarkers10▲ 3.6×14 topics
- Chronic Kidney Disease9▲ 9.8×8 topics
- Clinical Practice Guidelines9▲ 4.3×12 topics
- Heart Failure9▲ 5.3×9 topics
- Treatment Guidelines9▲ 10×5 topics
- Autoantibodies9▲ 9.6×8 topics
- Therapeutic Targets7▲ 13×5 topics
- Lymphoma7▲ 12×4 topics
- Cost-effectiveness Analysis7▲ 22×1 topic
- Health Utility Measures7▲ 22×1 topic
- Guidelines7▲ 3.9×8 topics
- Tumor Microenvironment7▲ 4.1×8 topics
- Chronic Lymphocytic Leukemia7▲ 39×1 topic
- Genomic Aberrations7▲ 39×1 topic
- Targeted Therapy7▲ 7.8×4 topics
- PET Imaging6▲ 9.9×4 topics
- Immunology6▲ 15×2 topics
- Thrombosis6▲ 5.7×6 topics
- Asthma6▲ 15×2 topics
- Cost of Care5▲ 47×1 topic
- Financial Toxicity5▲ 47×1 topic
- Genomic Profiling5▲ 14×2 topics
- Pulmonary Hypertension5▲ 9.8×3 topics
- Antiretroviral Therapy5▲ 8.4×6 topics
- Eosinophilia5▲ 26×2 topics
- Gene Expression Profiling5▲ 16×2 topics
Which research topics does Analysis Group (United States) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Chronic Lymphocytic Leukemia Research, Economic and Financial Impacts of Cancer and Asthma and respiratory diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 7 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 7 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 5 works
- 4 Asthma and respiratory diseases Physiology 5 works
- 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 6 Eosinophilic Disorders and Syndromes Rheumatology 4 works
- 7 Renal Diseases and Glomerulopathies Nephrology 4 works
- 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 4 works
- 9 Chronic Myeloid Leukemia Treatments Hematology 4 works
- 10 Muscle Physiology and Disorders Molecular Biology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Analysis Group (United States)'s research output changed?
Output in 2018–2022 was 10% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.